Join Us Live for a Discussion on Medicare, Democracy, and the Future of Health Care Starting in July 2026, some people with Medicare will be eligible for Medicare coverage of certain weight-loss medications through the new Medicare GLP1 Bridge Program
If you've been following the medical weight loss conversation, you already know that injectable drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have fundamentally changed how medicine approaches obesity and metabolic health
The data does not distinguish between overdoses tied to a telehealth prescription and those stemming from an in-person medical appointment, but it is a reflection of how prevalent these drugs have become
Clinically, it is considered among the least concerning for long-term use
Many people will feel hungry sooner after meals and will think about food more often
[DOI] [PMC free article] [PubMed] [Google Scholar] 31.Farah LX, et al